Switch to:
More From Other Websites
Alexion Pharmaceuticals: Nice Earnings, Too Expensive? Oct 23 2014
The Zacks Analyst Blog Highlights: AbbVie, Amgen, Regeneron, Pharmacyclics and Repros Therapeutics Oct 23 2014
Biotechs Show Fed Chief's Not Much Of A Stock Analyst Oct 22 2014
Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? Oct 22 2014
Biogen Leads 5 Top Biotech Stocks As Earnings Loom Oct 21 2014
The Market Thorns, Roses, and All Time Highs... Oct 21 2014
Three Big Cap Leaders Remain In Buy Range Oct 20 2014
Sanofi and Regeneron Dose Patients in Dupilumab Study Oct 20 2014
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate Oct 20 2014
3 Drugs Stocks Dragging The Industry Down Oct 20 2014
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis Oct 20 2014
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis Oct 20 2014
Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% Oct 20 2014
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema Oct 20 2014
Market Thorns, Roses, and All Time Highs... Oct 17 2014
[$$] Amgen Files Patent Infringement Suit Oct 17 2014
Two Tribes Go to War: Amgen Sues Regeneron for Patent Infringement Oct 17 2014
Cramer: Regeneron's Head-to-Head Results 'Very Positive' Oct 17 2014
Regeneron Eye Drug Beats Rivals While Amgen Sues Oct 17 2014
Stocks Power Higher At Open; Regeneron Vaults On Eylea Trial Oct 17 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK